Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
107.00    1.20 (1.13%)
Bid:
106.40
Ask:
109.80
Spread: 3.40 (3.195%)
Market Cap: £117.00m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Pricing Results of Convertible Notes Offering

4 Nov 2009 14:56

RNS Number : 9618B
Ford Motor Co
04 November 2009
 

Contact: Media: Mark Truby 313.323.0539 mtruby@ford.com

Equity Investment Community:  Larry Heck  313.594.0613 fordir@ford.com

Fixed Income Investment Community: Dave Dickenson 313.621.0881 fixedinc@ford.com

Shareholder Inquiries: 800.555.5259 or 313.845.8540 stockinf@ford.com

FORD MOTOR COMPANY ANNOUNCES PRICING RESULTS OF CONVERTIBLE NOTES OFFERING

DEARBORN, Mich., Nov. 3, 2009 - Ford Motor Company (NYSE: F) today announced the pricing of its offering of senior convertible notes due Nov. 15, 2016. Notes in the aggregate principal amount of $2.5 billion will be offered, an increase from the $2 billion previously announced. The notes will be senior unsecured obligations of Ford and will bear interest at a fixed rate of 4.25 percent per year. Ford has granted the underwriters an option to purchase an additional $375 million in aggregate principal amount of notes.

"This was a successful transaction and the results exceeded our expectations," said Lewis Booth, Ford executive vice president and chief financial officer. "This transaction directly supports a key pillar of our One Ford strategy - finance the plan and improve our balance sheet."

The sale of the notes to the underwriters is expected to settle on Nov. 9, subject to customary closing conditions.

The notes will be convertible, under certain circumstances, into shares of Ford common stock, cash or a combination thereof, at Ford's election. The initial conversion rate is 107.5269 shares of Ford common stock per $ 1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $9.30 per share. The conversion rate and the conversion price are subject to adjustment upon the occurrence of certain events.

Barclays Capital, BofA Merrill Lynch, Citi, Deutsche Bank Securities, Goldman Sachs & Co., J.P. Morgan, Morgan Stanley and RBS are acting as joint book-running managers of the notes offering. BNP Paribas and HSBC also will be included in the underwriting syndicate for the offering.

The senior convertible notes will be issued pursuant to Ford's existing effective shelf registration statement filed with the Securities and Exchange Commission (SEC). Net proceeds to Ford from the senior convertible notes offering are expected to be used for general corporate purposes.

Ford has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Investors should read the prospectus in the registration statement and other documents Ford has filed with the SEC for more complete information about Ford and the offering. The documents can be obtained free of charge through EDGAR on the SEC Web site at www.sec.gov. Alternatively, the prospectus and prospectus supplement can be obtained from the issuer and underwriters participating in the offering by calling: Ford at 800-555-5259, BofA Merrill Lynch at 866-500-5408, Citi at 877-858-5407, and J.P. Morgan at 631-254-1735.

About Ford Motor CompanyFord Motor Company, a global automotive industry leader based in Dearborn, Mich., manufactures or distributes automobiles across six continents. With about 200,000 employees and about 90 plants worldwide, the company's automotive brands include Ford, Lincoln, Mercury and Volvo. The company provides financial services through Ford Motor Credit Company.

###

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODFSFFLLSUSELF
Date   Source Headline
2nd Jul 20262:05 pmRNSNotice of Interim Results
1st Jul 20269:31 amRNSTotal Voting Rights
25th Jun 20262:22 pmRNSDirector/PCA Shareholding
19th Jun 20263:31 pmRNSNotification of Transaction of PDMR
19th Jun 20263:00 pmRNSNotification of Transactions of Directors
8th Jun 20268:24 amRNSDisclosure of PSP Performance Condition Targets
3rd Jun 202611:01 amRNSAdmission to Trading
2nd Jun 20262:23 pmRNSDirector Shareholding & Block Listing Application
1st Jun 20267:00 amRNSTotal Voting Rights
21st May 20264:39 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Statement
27th Apr 20263:51 pmRNSNotification of Transactions of Directors & PDMRs
21st Apr 20262:18 pmRNSDirector / PCA Shareholding
20th Apr 20267:00 amRNSDirector / PCA Shareholding
10th Apr 20264:34 pmRNS2026 Notice of Annual General Meeting
20th Mar 20265:18 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSPreliminary Results
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSTrading Statement
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
1st Dec 20259:17 amRNSTotal Voting Rights
13th Nov 202512:35 pmRNSHolding(s) in Company
11th Nov 20257:00 amRNSTrading Statement
6th Nov 20254:05 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
17th Oct 20251:03 pmRNSDirector/PDMR Shareholding
4th Sep 20254:31 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202510:55 amRNSDirector/PDMR Shareholding
5th Aug 202510:03 amRNSHolding(s) in Company
1st Aug 20258:50 amRNSTotal Voting Rights
31st Jul 20255:27 pmRNSPDMR Shareholding
31st Jul 20253:45 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSHalf-year Report
15th Jul 20255:07 pmRNSHolding(s) in Company
7th Jul 20259:48 amRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirectorate Change
6th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
23rd May 20255:07 pmRNSDirector/PCA Shareholding
20th May 20255:28 pmRNSResult of AGM
20th May 20257:00 amRNSAnnual General Meeting Statement
9th May 202511:10 amRNSDirector/PDMR Shareholding
8th May 20252:55 pmRNSDirector/PDMR Shareholding
1st May 20251:17 pmRNSDirector/PDMR Shareholding
23rd Apr 20259:51 amRNSDirector Shareholding
9th Apr 20254:32 pmRNSDirector/PDMR Shareholding
8th Apr 20255:42 pmRNSNotice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.